C299H463ClN56O54S17Si2 — CID 158074958
N-[4-(3-aminocyclopentyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(3-aminophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-aminophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-anilinophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[bis[2-[tert-butyl(dimethyl)silyl]oxyethyl]amino]phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;tert-butyl N-[1-[4-[5-(propan-2-ylsulfonylamino)pentanoylamino]phenyl]pyrrolidin-3-yl]carbamate;chloromethane;N-[4-(2,3-dihydroindol-1-yl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[3-(dimethylamino)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(1H-indazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-indol-1-ylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1H-indol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;(2S)-1-[4-[5-(propan-2-ylsulfonylamino)pentanoylamino]phenyl]pyrrolidine-2-carboxamide;5-(propan-2-ylsulfonylamino)-N-(4-pyrazol-1-ylphenyl)pentanamide;5-(propan-2-ylsulfonylamino)-N-[4-(tetrazol-2-yl)phenyl]pentanamide;5-(propan-2-ylsulfonylamino)-N-[4-(thiadiazol-4-yl)phenyl]pentanamide (PubChem CID 158074958) has the molecular formula C299H463ClN56O54S17Si2 and a molecular weight of 6343.10 g/mol. Its IUPAC name is N-[4-(3-aminocyclopentyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(3-aminophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-aminophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-anilinophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[bis[2-[tert-butyl(dimethyl)silyl]oxyethyl]amino]phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;tert-butyl N-[1-[4-[5-(propan-2-ylsulfonylamino)pentanoylamino]phenyl]pyrrolidin-3-yl]carbamate;chloromethane;N-[4-(2,3-dihydroindol-1-yl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[3-(dimethylamino)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(1H-indazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-indol-1-ylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1H-indol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;(2S)-1-[4-[5-(propan-2-ylsulfonylamino)pentanoylamino]phenyl]pyrrolidine-2-carboxamide;5-(propan-2-ylsulfonylamino)-N-(4-pyrazol-1-ylphenyl)pentanamide;5-(propan-2-ylsulfonylamino)-N-[4-(tetrazol-2-yl)phenyl]pentanamide;5-(propan-2-ylsulfonylamino)-N-[4-(thiadiazol-4-yl)phenyl]pentanamide.
| Compound Name | N-[4-(3-aminocyclopentyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(3-aminophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-aminophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-anilinophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[bis[2-[tert-butyl(dimethyl)silyl]oxyethyl]amino]phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;tert-butyl N-[1-[4-[5-(propan-2-ylsulfonylamino)pentanoylamino]phenyl]pyrrolidin-3-yl]carbamate;chloromethane;N-[4-(2,3-dihydroindol-1-yl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[3-(dimethylamino)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(1H-indazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-indol-1-ylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1H-indol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;(2S)-1-[4-[5-(propan-2-ylsulfonylamino)pentanoylamino]phenyl]pyrrolidine-2-carboxamide;5-(propan-2-ylsulfonylamino)-N-(4-pyrazol-1-ylphenyl)pentanamide;5-(propan-2-ylsulfonylamino)-N-[4-(tetrazol-2-yl)phenyl]pentanamide;5-(propan-2-ylsulfonylamino)-N-[4-(thiadiazol-4-yl)phenyl]pentanamide |
|---|---|
| PubChem CID | 158074958 |
| Molecular Formula | C299H463ClN56O54S17Si2 |
| Molecular Weight | 6343.10 g/mol |
| Exact Mass | 6336.97 |
| IUPAC Name | N-[4-(3-aminocyclopentyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(3-aminophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-aminophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-anilinophenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[bis[2-[tert-butyl(dimethyl)silyl]oxyethyl]amino]phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;tert-butyl N-[1-[4-[5-(propan-2-ylsulfonylamino)pentanoylamino]phenyl]pyrrolidin-3-yl]carbamate;chloromethane;N-[4-(2,3-dihydroindol-1-yl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[3-(dimethylamino)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(1H-indazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-indol-1-ylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1H-indol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;(2S)-1-[4-[5-(propan-2-ylsulfonylamino)pentanoylamino]phenyl]pyrrolidine-2-carboxamide;5-(propan-2-ylsulfonylamino)-N-(4-pyrazol-1-ylphenyl)pentanamide;5-(propan-2-ylsulfonylamino)-N-[4-(tetrazol-2-yl)phenyl]pentanamide;5-(propan-2-ylsulfonylamino)-N-[4-(thiadiazol-4-yl)phenyl]pentanamide |
| SMILES | CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(-c2csnn2)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(-n2ccc3ccccc32)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(-n2cccn2)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(-n2ncnn2)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(C2CCC(N)C2)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(N(CCO[Si](C)(C)C(C)(C)C)CCO[Si](C)(C)C(C)(C)C)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(N)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(N2CCC(NC(=O)OC(C)(C)C)C2)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(N2CCC[C@H]2C(N)=O)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(N2CCc3ccccc32)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(N2C[C@@H](C)O[C@@H](C)C2)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(Nc2ccccc2)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc2[nH]ccc2c1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc2[nH]ncc2c1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1cccc(N(C)C)c1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1cccc(N)c1.CCl |
| InChI | InChI=1S/C30H59N3O5SSi2.C23H38N4O5S.C22H29N3O3S.C22H27N3O3S.C20H33N3O4S.C20H27N3O3S.C19H30N4O4S.C19H31N3O3S.C17H24N4O3S.C16H22N4O3S2.C16H23N3O3S.C16H27N3O3S.C15H22N6O3S.C15H22N4O3S.2C14H23N3O3S.CH3Cl/c1-25(2)39(35,36)31-20-14-13-15-28(34)32-26-16-18-27(19-17-26)33(21-23-37-40(9,10)29(3,4)5)22-24-38-41(11,12)30(6,7)8;1-17(2)33(30,31)24-14-7-6-8-21(28)25-18-9-11-20(12-10-18)27-15-13-19(16-27)26-22(29)32-23(3,4)5;2*1-17(2)29(27,28)23-15-6-5-9-22(26)24-19-10-12-20(13-11-19)25-16-14-18-7-3-4-8-21(18)25;1-15(2)28(25,26)21-12-6-5-7-20(24)22-18-8-10-19(11-9-18)23-13-16(3)27-17(4)14-23;1-16(2)27(25,26)21-15-7-6-10-20(24)23-19-13-11-18(12-14-19)22-17-8-4-3-5-9-17;1-14(2)28(26,27)21-12-4-3-7-18(24)22-15-8-10-16(11-9-15)23-13-5-6-17(23)19(20)25;1-14(2)26(24,25)21-12-4-3-5-19(23)22-18-10-7-15(8-11-18)16-6-9-17(20)13-16;1-14(2)25(23,24)19-12-4-3-6-17(22)20-15-7-9-16(10-8-15)21-13-5-11-18-21;1-12(2)25(22,23)17-10-4-3-5-16(21)18-14-8-6-13(7-9-14)15-11-24-20-19-15;1-12(2)23(21,22)18-9-4-3-5-16(20)19-14-6-7-15-13(11-14)8-10-17-15;1-13(2)23(21,22)17-11-6-5-10-16(20)18-14-8-7-9-15(12-14)19(3)4;1-12(2)25(23,24)18-10-4-3-5-15(22)19-13-6-8-14(9-7-13)21-17-11-16-20-21;1-11(2)23(21,22)17-8-4-3-5-15(20)18-13-6-7-14-12(9-13)10-16-19-14;1-11(2)21(19,20)16-9-4-3-8-14(18)17-13-7-5-6-12(15)10-13;1-11(2)21(19,20)16-10-4-3-5-14(18)17-13-8-6-12(15)7-9-13;1-2/h16-19,25,31H,13-15,20-24H2,1-12H3,(H,32,34);9-12,17,19,24H,6-8,13-16H2,1-5H3,(H,25,28)(H,26,29);3-4,7-8,10-13,17,23H,5-6,9,14-16H2,1-2H3,(H,24,26);3-4,7-8,10-14,16-17,23H,5-6,9,15H2,1-2H3,(H,24,26);8-11,15-17,21H,5-7,12-14H2,1-4H3,(H,22,24);3-5,8-9,11-14,16,21-22H,6-7,10,15H2,1-2H3,(H,23,24);8-11,14,17,21H,3-7,12-13H2,1-2H3,(H2,20,25)(H,22,24);7-8,10-11,14,16-17,21H,3-6,9,12-13,20H2,1-2H3,(H,22,23);5,7-11,13-14,19H,3-4,6,12H2,1-2H3,(H,20,22);6-9,11-12,17H,3-5,10H2,1-2H3,(H,18,21);6-8,10-12,17-18H,3-5,9H2,1-2H3,(H,19,20);7-9,12-13,17H,5-6,10-11H2,1-4H3,(H,18,20);6-9,11-12,18H,3-5,10H2,1-2H3,(H,19,22);6-7,9-11,17H,3-5,8H2,1-2H3,(H,16,19)(H,18,20);5-7,10-11,16H,3-4,8-9,15H2,1-2H3,(H,17,18);6-9,11,16H,3-5,10,15H2,1-2H3,(H,17,18);1H3/t;;;;16-,17+;;17-;;;;;;;;;;/m......0........../s1 |
| InChIKey | FMGHVVZWXRIIEG-QDDIFZQBSA-N |
| XLogP | 46.09 |
| TPSA | 1559.56 Ų |
| H-Bond Donors | 40 |
| H-Bond Acceptors | 75 |
| Rotatable Bonds | 151 |
| Heavy Atoms | 429 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 6343.10 |
| LogP ≤ 5 | 46.09 |
| H-Bond Donors ≤ 5 | 40 |
| H-Bond Acceptors ≤ 10 | 75 |